Pressure-reducing efficacy and tolerability of betaxolol in ionic solution.
Troiano
P
P
Eye Clinic, University of Milan.
Cavallotti
B
B
Iraci
M
M
Galli
L
L
Miglior
M
M
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000368:Aged; D015784:Betaxolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005902:Glaucoma, Open-Angle / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D012117:Resins, Synthetic; D012449:Safety; D016037:Single-Blind Method; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D012117:Resins, Synthetic; C046797:amberlite; D015784:Betaxolol